Softgel Capsule Market, by Product Type (Gelatin Softgel Capsule and Non-gelatin Softgel Capsule), by Source Type (Gelatin Type-A, Gelatin Type-B, Hydroxy Propyl Methyl Cellulose (HPMC), and Others), by Application (Anti-inflammatory Drugs, Antibiotic Dru

Softgel Capsule Market, by Product Type (Gelatin Softgel Capsule and Non-gelatin Softgel Capsule), by Source Type (Gelatin Type-A, Gelatin Type-B, Hydroxy Propyl Methyl Cellulose (HPMC), and Others), by Application (Anti-inflammatory Drugs, Antibiotic Drugs, Health Supplements, Cardiovascular Drugs, and Others), by End User (Pharmaceutical Companies, Contract Manufacturing Organizations, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

A softgel capsule is an oral dosage form similar to medicinal hard gelatin capsule. The softgel capsules are manufactured by the process known as encapsulation using the rotary die encapsulation process. The outer surrounding of the softgel capsule is mainly manufactured using natural or animal source derived gelatin such as gelatin type-A, gelatin type-B, and can also be manufactured by using Hydroxy Propyl Methyl Cellulose (HPMC). The soft gelatin capsules are coated with the gelatin, which is a type of collagen protein that can be easily digested in the human intestinal tract. Therefore these softgel capsules are easily broken down in the human digestive system, indicating better drug absorption.
Market Dynamics
The global softgel capsule market is expected to witness significant growth during the forecast period, owing to increasing market players focusing on product launches and product approvals, in order to strengthen their position in the softgel capsule market. For instance, in 2019, Sirio Pharma Company Ltd, received European Patent for softgel capsule, which contains active probiotic bacteria and omega-3 oil for the treatment of individuals suffering from digestive problems.
Key features of the study:
This report studies the current scenario as well as the future potential for the global softgel capsules market. The market for softgel capsule is segmented on the basis of product type, source type, application, end user, and region.
This report provides in-depth analysis of the global softgel capsule market and provides market size (US$ Mn) and compound annual growth rate (CAGR) (%) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market. It provides valuable insights about market drivers, restraints, opportunities, country outlook, and competitive strategy adopted by the leading players.
It profiles leading players in the global softgel capsule market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, key developments, and future plans
Insights from this report would allow marketers and management authorities of companies to make informed decisions with respect to future market expansion and marketing tactics
The global softgel capsule market report caters to various stakeholders in this industry, including investors, product developers and manufacturers, distributors, healthcare organizations, research institutes, new entrants, and financial analysts
Stakeholders would greatly benefit in decision making through the various strategy matrices used in analyzing the global softgel capsule market.
Detailed Segmentation:
Global Softgel Capsule Market, By Product Type:
Gelatin Softgel Capsule
Non-gelatin Softgel Capsule
Global Softgel Capsule Market, By Source Type:
Gelatin Type-A
Gelatin Type-B
Hydroxy Propyl Methyl Cellulose (HPMC)
Others
Global Softgel Capsule Market, By Application:
Anti-inflammatory Drugs
Antibiotic Drugs
Health Supplements
Cardiovascular Drugs
Others
Global Softgel Capsule Market, By End User:
Pharmaceutical Companies
Contract Manufacturing Organizations
Others
Global Softgel Capsule Market, By Region:
North America
By Product Type:
Gelatin Softgel Capsule
Non-gelatin Softgel Capsule
By Source Type:
Gelatin Type-A
Gelatin Type-B
Hydroxy Propyl Methyl Cellulose (HPMC)
Others
By Application:
Anti-inflammatory Drugs
Antibiotic Drugs
Health Supplements
Cardiovascular Drugs
Others
By End User
Pharmaceutical Companies
Contract Manufacturing Organizations
Others
By Country:
U.S.
Canada
Latin America
By Product Type:
Gelatin Softgel Capsule
Non-gelatin Softgel Capsule
By Source Type:
Gelatin Type-A
Gelatin Type-B
Hydroxy Propyl Methyl Cellulose (HPMC)
Others
By Application:
Anti-inflammatory Drugs
Antibiotic Drugs
Health Supplements
Cardiovascular Drugs
Others
By End User
Pharmaceutical Companies
Contract Manufacturing Organizations
Others
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Product Type:
Gelatin Softgel Capsule
Non-gelatin Softgel Capsule
By Source Type:
Gelatin Type-A
Gelatin Type-B
Hydroxy Propyl Methyl Cellulose (HPMC)
Others
By Application:
Anti-inflammatory Drugs
Antibiotic Drugs
Health Supplements
Cardiovascular Drugs
Others
By End User
Pharmaceutical Companies
Contract Manufacturing Organizations
Others
By Country:
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
By Product Type:
Gelatin Softgel Capsule
Non-gelatin Softgel Capsule
By Source Type:
Gelatin Type-A
Gelatin Type-B
Hydroxy Propyl Methyl Cellulose (HPMC)
Others
By Application:
Anti-inflammatory Drugs
Antibiotic Drugs
Health Supplements
Cardiovascular Drugs
Others
By End User
Pharmaceutical Companies
Contract Manufacturing Organizations
Others
By Country:
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Product Type:
Gelatin Softgel Capsule
Non-gelatin Softgel Capsule
By Source Type:
Gelatin Type-A
Gelatin Type-B
Hydroxy Propyl Methyl Cellulose (HPMC)
Others
By Application:
Anti-inflammatory Drugs
Antibiotic Drugs
Health Supplements
Cardiovascular Drugs
Others
By End User
Pharmaceutical Companies
Contract Manufacturing Organizations
Others
By Country:
GCC
Israel
Rest of Middle East
Africa
By Product Type:
Gelatin Softgel Capsule
Non-gelatin Softgel Capsule
By Source Type:
Gelatin Type-A
Gelatin Type-B
Hydroxy Propyl Methyl Cellulose (HPMC)
Others
By Application:
Anti-inflammatory Drugs
Antibiotic Drugs
Health Supplements
Cardiovascular Drugs
Others
By End User
Pharmaceutical Companies
Contract Manufacturing Organizations
Others
By Country/Region:
South Africa
Central Africa
North Africa
Company Profiles
Catalent, Inc*
Company Overview
Material Portfolio
Financial Performance
Key Highlights
Market Strategies
Aenova Group GmbH
Sirio Pharma Company Ltd
Captek Softgel International Inc
Elnova Pharma
Fuji Capsule Co., Ltd.
Capsugel
EuroCaps Ltd
Guangdong Yichao Biological Co., Ltd.
Hunan ER-KANG Pharmaceutical Co Ltd
KD Pharma Group
“*” marked represents similar segmentation in other categories in the respective section.